Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 28, 2012; 18(36): 5065-5071
Published online Sep 28, 2012. doi: 10.3748/wjg.v18.i36.5065
Published online Sep 28, 2012. doi: 10.3748/wjg.v18.i36.5065
Figure 1 Disease activity index before and after treatment in all patients.
In the left part of the graph, there are disease activity index (DAI) values for every patient affected by ulcerative colitis or Crohn's disease at enrollment. In the right part of the graph, there are DAI values for every patient after treatment.
- Citation: Merra G, Gasbarrini G, Laterza L, Pizzoferrato M, Poscia A, Scaldaferri F, Arena V, Fiore F, Cittadini A, Sgambato A, Franceschi F, Gasbarrini A. Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases. World J Gastroenterol 2012; 18(36): 5065-5071
- URL: https://www.wjgnet.com/1007-9327/full/v18/i36/5065.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i36.5065